M&A Deal Summary

Allergan Acquires Allergan

On March 17, 2015, Allergan acquired life science company Allergan for 70.5B USD

Acquisition Highlights
  • This is Allergan’s 13th transaction in the Life Science sector.
  • This is Allergan’s largest (disclosed) transaction.
  • This is Allergan’s 12th transaction in the United States.
  • This is Allergan’s 2nd transaction in California.

M&A Deal Summary
Date 2015-03-17
Target Allergan
Sector Life Science
Buyer(s) Allergan
Deal Type Add-on Acquisition
Deal Value 70.5B USD
Advisor(s) Goldman Sachs
BofA Securities (Financial)
Latham & Watkins
Wachtell, Lipton, Rosen & Katz (Legal)

Target

Allergan

Irvine, California, United States
Allergan, Inc. is a pharmaceutical company. Allergan's products include ophthalmic pharmaceuticals, dermatology products, and neurological products.

Search 192,723 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Allergan

Parsippany, New Jersey, United States

website

Category Company
Founded 1956
Sector Life Science
Employees31,200
Revenue 15.8B USD (2018)
DESCRIPTION

Allergan is an integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company was originally established in 1956 and is based in Parsippany, New Jersey.

DEAL STATS #
Overall 20 of 38
Sector (Life Science) 13 of 23
Type (Add-on Acquisition) 15 of 31
State (California) 2 of 9
Country (United States) 12 of 27
Year (2015) 2 of 5
Size (of disclosed) 1 of 25
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-02-24 Actavis Doryx Brand and Related Assets

United States

Actavis Doryx Brand and Related Assets comprises the Doryx trademark, marketing materials, select product inventory, and related medical and technical data.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-04-02 Adare Pharmaceuticals

Lawrenceville, New Jersey, United States

Adare Pharmaceuticals provides enhanced medicines, creating new possibilities for improved patient health. FAdare Pharmaceuticals has solved complex formulation, manufacturing, and commercialization challenges, resulting in transformational medicines that deliver value to all its stakeholders. Adare Pharmaceuticals has a global presence with R&D, manufacturing, and commercial operations in the Unites States, Europe, and Canada. Adare Pharmaceuticals was founded in 2015 and is based in Lawrenceville, New Jersey.

Sell -
Mergr

Product

Company

Legal